#863: Elad Gil, Consigliere to Empire Builders — How to Spot Billion-Dollar Companies Before Everyone Else, The Misty AI Frontier, How Coke Beat Pepsi, When Consensus Pays, and Much More

Elad Gil (@eladgil) is CEO of Gil & Co, a multi-stage investment firm, holding company, and operating company working on the world’s most advanced technologies. Elad is a serial entrepreneur, operating executive, and investor or advisor to private companies, including AirBnB, Anduril, Coinbase, Figma, Instacart, OpenAI, SpaceX, and Stripe. He was previously VP of Corporate Strategy at Twitter and started mobile at Google. He was the founder and CEO of Mixerlabs and Color. Elad is the author of the bestseller High Growth Handbook: Scaling Startups from 10 to 10,000 People.

This episode is brought to you by:

Matic the intelligent robot vacuum and mop that navigates obstacles and needs no babysitting: MaticRobots.com/Tim
AG1 all-in-one nutritional supplement: DrinkAG1.com/Tim
Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating: EightSleep.com/Tim
Helix Sleep premium mattresses: HelixSleep.com/Tim

Timestamps

[00:00:00] Start.
[00:02:21] What’s the “AI personal IPO” that just quietly happened across Silicon Valley?
[00:05:28] Tens to hundreds of millions per researcher: What top AI pay packages actually look like.
[00:06:44] The compute ceiling: Why Korean memory fabs are the unlikely bottleneck throttling every AI lab on earth.
[00:11:11] From zero to $30B run rate: The fastest revenue ramps in the history of capitalism.
[00:17:24] The dot-com survival rate was one in 100. Buckle up, AI founders.
[00:20:35] Your value-maximizing window: Why the next 12–18 months may be as good as it gets.
[00:21:32] Durable advantage — and why the AI market is an oligopoly (for now).
[00:24:12] Exit options for AI founders: labs, hyperscalers, vertical players, and the underrated merger of equals.
[00:28:11] Math, biology, and intuitive leaps: Elad’s pre-investing background.
[00:29:42] Elad’s revisionist genesis story.
[00:30:50] Go where the cluster is: 91% of global AI private market cap lives in a 10×10 mile square.
[00:33:20] The accidental investor: Patrick Collison walks, Airbnb intros, and deals that just happened.
[00:34:37] Want money? Ask for advice. Want advice? Ask for money.
[00:35:00] The High Growth Handbook: Tactical guide, not bedtime reading.
[00:35:41] Market first, team second — with a Perplexity-and-Anduril asterisk.
[00:37:43] Smoke in the distance: AlexNet and the transformative GPT-3 moment.
[00:45:15] AI cold-reading: Feeding photos to the model and getting eerily accurate personality reads.
[00:48:56] Has Elad ever done a retrospective on his own investing?
[00:52:13] Power laws are terrifying: 10 companies, 80% of returns, two decades.
[00:55:53] Avoiding science projects, and how SPACs accidentally saved hard tech investing.
[00:59:20] The one-belief framework: Coinbase = crypto index. Stripe = e-commerce index. That’s the whole memo.
[01:00:54] Due diligence theater vs. the one question that actually matters.
[01:02:13] The four-year vest is a relic: How venture capital ate growth investing.
[01:07:16] Boards as in-laws: You can’t fire them, so choose wisely.
[01:09:47] “Valuation is temporary. Control is forever.” — Naval Ravikant, as quoted by Elad, as relayed to you.
[01:11:30] How great companies actually grew: toolbars, name-targeted ads, and billions in distribution spend.
[01:15:36] Selling software vs. selling labor hours: The real shift generative AI made.
[01:18:40] Spotting a great market: regulatory shifts, technology shifts, and Hashi getting bought by IBM.
[01:21:28] Fake TAM, real TAM, and the Coke CEO who realized he wasn’t in the soda business.
[01:22:47] Right now, consensus is just correct. Save the contrarianism for later.
[01:25:15] Market entry vs. market disruption: SpaceX launched rockets, then disrupted the internet.
[01:26:16] How Elad learns: X, papers, 20-minute calls with the right people — and four AI models running in parallel.
[01:27:15] Deep dive: ADHD, autism, and why diagnostic rates soared without more people actually having it.
[01:33:40] Longevity for realists: sleep, creatine, and maybe rapamycin when the real drugs arrive.
[01:40:30] Ibogaine, anesthesia, and the next frontier of bioelectric medicine.
[01:45:15] Elad’s first-ever 10-year plan — and why making one changes everything.
[01:46:53] Parting thoughts.

For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.

For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsors

Sign up for Tim’s email newsletter (5-Bullet Friday) at tim.blog/friday.

For transcripts of episodes, go to tim.blog/transcripts.

Discover Tim’s books: tim.blog/books.

Follow Tim:

Twitter: twitter.com/tferriss

Instagram: instagram.com/timferriss

YouTube: youtube.com/timferriss

Facebook: facebook.com/timferriss

LinkedIn: linkedin.com/in/timferriss

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(884)

#880: Relationship Tools That Work — Esther Perel, Brené Brown, Dr. Sue Johnson, Terry Real, and More on Conflict, Repair, and Lasting Love

This episode is devoted to one deceptively simple question: How do you stay close to your partner over time through the inevitable exhaustion, misunderstanding, conflict, disappointment, and change?Th...

19 Aug 57min

#879: How to Reinvent Yourself and Make Bold Moves — Decisive Stories from Matthew McConaughey, Steve Young, Samin Nosrat, and More

This is a special compilation devoted to reinvention: how to shed an identity that no longer fits, decide on a new chapter, navigate uncertainty, and commit to what’s next.This episode is brought to y...

12 Aug 1h 1min

#878: How to Start When You're Stuck, Finish What You Begin, and Stop Waiting for Inspiration — Creative Advice from Elizabeth Gilbert, Seth Godin, Joyce Carol Oates, Anne Lamott and More

This is a special compilation devoted to a subject very close to my heart and currently consuming a large percentage of my waking hours: writing. Over the years, I’ve asked some of the writers I admir...

5 Aug 58min

#877: Q&A with Tim — The Art of Male Friendship, Mini-Retirements, Higher-Resolution Living, Reinvention in The Age of AI, and More

In this wide-ranging Q&A, Tim explores reinvention, enduring skills for the age of AI, friendship, mental health, fitness, language learning, privacy, cognitive longevity, and more.This episode is bro...

29 Juli 1h 15min

#876: Dr. Andrew Huberman — Peptides, Performance, and Protocols

Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is ...

22 Juli 2h 14min

#875: The Random Show — Tim and Kevin Talk Retreats, Mortality, AI Predictions, Supplements, Rock Climbing at (Almost) 50, and Not Waiting for “Someday”

In this edition of The Random Show, Tim Ferriss and Kevin Rose reunite over tequila to talk Zen retreats, learning to rock climb at (almost) 50, mortality and grief, why you should stop saying "one da...

16 Juli 1h 58min

#874: Guy Oseary — The Legendary Hollywood Power Broker on 5-Minute Decisions, 36 Years of Managing Madonna, 26 IPOs, and Spotting Magic First

Guy Oseary (@guyoseary) has been spotting talent before anyone else could see it for nearly four decades. Under his leadership at Maverick Records, Maverick sold more than 100 million albums. Guy has ...

7 Juli 1h 32min

#873: David Allen — The Art of Getting Things Done (GTD) (Repost)

For more than 40 years, David Allen has worked with individuals and organizations around the world to help them stay clear, focused, and productive—without burning out. He is the author of the mega-be...

2 Juli 1h 31min